Tools
Programs
Blood
A healthy blood system is essential to all human life. We are investigating what constitutes a healthy blood system and diligently working on improving bone marrow and cord blood transplants. These blood products are important to all oncology programs. Blood transfusion products are required in routine cancer treatment to support chemotherapy regimens and bone marrow transplantation is the only curative procedure for eligible patients with leukemia.
Principal Investigators
Related Projects
To develop cell-based tools for use in drug screening of patient-specific stem cells.
To identify novel therapeutics that can target the bone marrow environment to destroy and prevent leukemia. By better understanding the optimal bone marrow conditions needed to support healthy blood stem cells, this study also has the potential to improve stem cell transplantation therapies.
The combination of standard of care chemotherapy, coupled with novel drugs discovered by our group, is hoped to prevent cancer relapse.
Related News
Hitting the Bullseye on Cancer Stem Cells
A team of researchers led by Dr. Mick Bhatia has identified a unique feature of cancer stem cells that can be exploited to kill the deadly cells thought to be the reason that cancer comes back after therapy. [...]
Paige Collins | Thursday, June 22, 2017
SCC-RI Alumnus Leading German Cancer Immunotherapy Group
Bhatia Lab alumnus Dr. Borhane Guezguez is leading a new investigator group for cancer immunotherapy in Germany. [...]
Paige Collins | Wednesday, May 10, 2017
Highlights From McMaster's 5th Annual StemCell Talks Symposium
StemCellTalks organizers, Solen Abdulla and Michelle Ly, provide their highlights from the symposium's 5th year at McMaster. [...]
Solen Abdulla | Friday, April 28, 2017